Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Robert Elsby, Hayley Atkinson, Philip Butler & Robert J. Riley. (2022) Studying the right transporter at the right time: an in vitro strategy for assessing drug-drug interaction risk during drug discovery and development. Expert Opinion on Drug Metabolism & Toxicology 18:10, pages 619-655.
Read now
Read now
Donna A. Volpe, Abhay Joshi & Vikram Arya. (2022) Do differences in cell lines and methods used for calculation of IC50 values influence categorisation of drugs as P-glycoprotein substrates and inhibitors?. Xenobiotica 52:7, pages 751-757.
Read now
Read now
Zhengyue Qian, Cheng Huang, Chenlin Shen, Xiaoming Meng, Zhaolin Chen, Tingting Hu, Yangyang Li & Jun Li. (2016) The permeability characteristics and interaction of the main components from Zhizi Bopi decoction in the MDCK cell model. Xenobiotica 46:8, pages 733-742.
Read now
Read now
Donna A. Volpe. (2016) Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery 11:1, pages 91-103.
Read now
Read now
ANDREA JOHN, STEFANIE HESSEL, ALFONSO LAMPEN & ALBRECHT SEIDEL. (2012) Analysis of GSH Conjugates of Bay- and Fjord-Region Dihydrodiol Epoxides of Benzo[a]pyrene and Dibenzo[a,l]pyrene and their Transport in Enterocyte-like Caco-2 Cells. Polycyclic Aromatic Compounds 32:2, pages 221-237.
Read now
Read now
Clemence Tarirai, Alvaro M. Viljoen & Josias H. Hamman. (2012) Effects of dietary fruits, vegetables and a herbal tea on the in vitro transport of cimetidine: Comparing the Caco-2 model with porcine jejunum tissue. Pharmaceutical Biology 50:2, pages 254-263.
Read now
Read now
Donna A Volpe. (2011) Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines. Future Medicinal Chemistry 3:16, pages 2063-2077.
Read now
Read now
Robert Elsby, Veronica Smith, Lisa Fox, David Stresser, Caroline Butters, Pradeep Sharma & Dominic D. Surry. (2011) Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions. Xenobiotica 41:9, pages 764-783.
Read now
Read now
H. Glavinas, O. von Richter, K. Vojnits, D. Mehn, I. Wilhelm, T. Nagy, J. Janossy, I. Krizbai, P. Couraud & P. Krajcsi. (2011) Calcein assay: a high-throughput method to assess P-gp inhibition. Xenobiotica 41:8, pages 712-719.
Read now
Read now
. (2010) Invited Speakers. Drug Metabolism Reviews 42:sup1, pages 1-323.
Read now
Read now
P. Sharma, V. E. Holmes, R. Elsby, C. Lambert & D. Surry. (2010) Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions. Xenobiotica 40:1, pages 24-37.
Read now
Read now
K.S. Frederick, T.S. Maurer, A.S. Kalgutkar, L.J. Royer, O.L. Francone, S.M. Winter, S.G. Terra, D. Chen & X. Gao. (2009) Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human. Xenobiotica 39:10, pages 766-781.
Read now
Read now
Nuggehally R Srinivas & Mullangi Ramesh. (2009) Digoxin – a Therapeutic Agent and Mechanistic Probe: Review of Liquid Chromatographic Mass Spectrometric Methods and Recent Nuances in the Clinical Pharmacology Attributes of Digoxin. Bioanalysis 1:1, pages 97-113.
Read now
Read now
Articles from other publishers (100)
Brad Christopher Hansen, Kirk Peter Van Ness & Edward John Kelly. 2024. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Elias C. Padilha, Mengbi Yang, Pranav Shah, Amy Q. Wang, Jianmin Duan, Joshua K. Park, Charles N. Zawatsky, May Christine V. Malicdan, George Kunos, Malliga R. Iyer, Geneviève Gaucher, François Ravenelle, Resat Cinar & Xin Xu. (2023) In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis. Biomedicine & Pharmacotherapy 168, pages 115178.
Crossref
Crossref
Yu. S. Tranova, A. A. Slepnev, I. V. Chernykh, A. V. Shchulkin, P. Yu. Mylnikov, N. M. Popova, M. I. Povetko & E. N. Yakusheva. (2023) Method for Testing of Drugs Belonging to Substrates and Inhibitors of the Transporter Protein BCRP on Caco-2 Cells. Drug development & registration 12:2, pages 87-94.
Crossref
Crossref
Robert Elsby, Hannah Coghlan, Jacob Edgerton, David Hodgson, Samuel Outteridge & Hayley Atkinson. (2023)
Mechanistic in vitro studies indicate that the clinical drug–drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal
BCRP
and hepatic
OATP1B1
with minimal contribution from
OATP1B3
,
NTCP
and
OAT3
. Pharmacology Research & Perspectives 11:2.
Crossref
Crossref
Csilla Temesszentandrási-Ambrus, Gábor Nagy, Annamária Bui & Zsuzsanna Gáborik. (2023) A Unique In Vitro Assay to Investigate ABCB4 Transport Function. International Journal of Molecular Sciences 24:5, pages 4459.
Crossref
Crossref
Yajuan Bi, Xue Wang, Hui Ding, Feng He, Lifeng Han & Youcai Zhang. (2022) Transporter-mediated Natural Product-Drug Interactions. Planta Medica 89:02, pages 119-133.
Crossref
Crossref
A. V. Shchulkin, Yu. S. Tranova, Yu. V. Abalenikhina, A. S. Esenina, A. A. Slepnev & E. N. Yakusheva. (2023) Cells of the Caco-2 line as a model for studying the absorption of medicinal substances. Experimental and Clinical Gastroenterology:10, pages 63-69.
Crossref
Crossref
Katrina L. Mealey, Jane G. Owens & Elaine Freeman. (2022) Canine and feline P‐glycoprotein deficiency: What we know and where we need to go. Journal of Veterinary Pharmacology and Therapeutics 46:1, pages 1-16.
Crossref
Crossref
Yulia V. Abalenikhina, Pavel Yu. Mylnikov, Alexey V. Shchulkin & Elena N. Yakusheva. (2022) Inhibitory effect of DL-butionine sulfoximine on P-glycoprotein activity in vitro. Kazan medical journal 103:5, pages 780-787.
Crossref
Crossref
Daniel Porat, Oleg Dukhno, Ella Vainer, Sandra Cvijić & Arik Dahan. (2022) Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery. Molecular Pharmaceutics 19:8, pages 2922-2936.
Crossref
Crossref
Sonia Saib, Sophie Hodin, Clément Mercier, Mireille Paul, Valérie Bin, Edouard Ollier & Xavier Delavenne. (2022)
TNF-α and IL-1β Exposure Modulates the Expression and Functionality of
P
-Glycoprotein in Intestinal and Renal Barriers
. Molecular Pharmaceutics 19:7, pages 2327-2334.
Crossref
Crossref
Yu. V. Abalenikhina, P. D. Erokhina, P. Yu. Mylnikov, A. V. Shchulkin & E. N. Yakusheva. (2022) Functioning of the P-glycoprotein Membrane Transport Protein under Conditions of the Inhibition of Glutathione Synthesis. Applied Biochemistry and Microbiology 58:3, pages 232-242.
Crossref
Crossref
Athar Husain, Vishal Makadia, Guru R. Valicherla, Mohammed Riyazuddin & Jiaur R. Gayen. (2022) Approaches to minimize the effects of P‐glycoprotein in drug transport: A review. Drug Development Research 83:4, pages 825-841.
Crossref
Crossref
Aleksey V. Shchulkin, Yulia V. Abalenikhina, Elena A. Sudakova, Pavel Yu. Mylnikov & Elena N. Yakusheva. (2022) Mechanisms of Regulation of the P-Glycoprotein Transporter Protein Functioning under the Action of Nitric Oxide. Biochemistry (Moscow) 87:4, pages 366-379.
Crossref
Crossref
May Phyu Thein Maw, Nusara Piyapolrungroj, Panadda Phattanawasin & Chanokporn Sukonphan. (2022) Oxypeucedanin Hydrate: A Natural Furanocoumarin as P-Glycoprotein Substrate. Key Engineering Materials 914, pages 129-134.
Crossref
Crossref
Sonia Saib, Sophie Hodin, Valérie Bin, Edouard Ollier & Xavier Delavenne. (2021) In Vitro Evaluation of P-gp-Mediated Drug–Drug Interactions Using the RPTEC/TERT1 Human Renal Cell Model. European Journal of Drug Metabolism and Pharmacokinetics 47:2, pages 223-233.
Crossref
Crossref
Hayley Atkinson, Robert Elsby & Philip Butler. 2022. The ADME Encyclopedia. The ADME Encyclopedia
436
447
.
Hayley Atkinson, Kieron Mahon-Smith & Robert Elsby. 2022. The ADME Encyclopedia. The ADME Encyclopedia
401
412
.
Burak Ozgür, Lasse Saaby, Christian Janfelt, Kristine Langthaler, Elin Eneberg, Anne-Marie Jacobsen, Lassina Badolo, Dino Montanari & Birger Brodin. (2021) Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice. European Journal of Pharmaceutics and Biopharmaceutics 169, pages 211-219.
Crossref
Crossref
A. V. Shchulkin, Yu. V. Abalenikhina, A. A. Seidkulieva, I. V. Chernykh & E. N. Yakusheva. (2021) The Effect of Oxidative Stress on the Transport of the P-Glycoprotein Substrate through the Cell Monolayer. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 15:3, pages 257-269.
Crossref
Crossref
Laurens F. M. Verscheijden, Carlijn H. C. Litjens, Jan B. Koenderink, Ron H. J. Mathijssen, Marcel M. Verbeek, Saskia N. de Wildt & Frans G. M. Russel. (2021) Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children. PLOS Computational Biology 17:3, pages e1008786.
Crossref
Crossref
А.В. Щулькин, Ю.В. Абаленихина, И.В. Черных, П.Д. Ерохина & Е.Н. Якушева. (2021) Роль P-гликопротеина в ограничении проницаемости клеточных мембран при окислительном стрессе. Биохимия 86:2, pages 236-247.
Crossref
Crossref
Alexey V. Shchulkin, Yulia V. Abalenikhina, Pelageya D. Erokhina, Ivan V. Chernykh & Elena N. Yakusheva. (2021) The Role of P-Glycoprotein in Decreasing Cell Membranes Permeability during Oxidative Stress. Biochemistry (Moscow) 86:2, pages 197-206.
Crossref
Crossref
Shun Zhang, Yan Zhao, Shuyuan Wang, Min Li, Yue Xu, Jianhua Ran, Xiaoqiang Geng, Jinzhao He, Jia Meng, Guangying Shao, Hong Zhou, Zemei Ge, Guangping Chen, Runtao Li & Baoxue Yang. (2021) Discovery of novel diarylamides as orally active diuretics targeting urea transporters. Acta Pharmaceutica Sinica B 11:1, pages 181-202.
Crossref
Crossref
Hayley Atkinson, Robert Elsby & Philip Butler. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
13
.
Hayley Atkinson, Kieron Mahon-Smith & Robert Elsby. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
13
.
Sid Bhoopathy, Chris Bode, Vatsala Naageshwaran, Erica Weiskircher-Hildebrandt, Venkata Mukkavilli & Ismael J. Hidalgo. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
339
365
.
Ivan Vladimirovich Chernykh, Aleksey Vladimirovich Shchul'kin, Yekaterina Yevgen'yevna Kirichenko, Sergey Konstantinovich Pravkin & Yelena Nikolayevna Yakusheva. (2020) INFLUENCE OF POLYSACCHARIDE COMPLEXES OF PLANTS OF CENTRAL RUSSIA ON THE P-GLYCOPROTEIN ACTIVITY IN VITRO. chemistry of plant raw material:4, pages 73-81.
Crossref
Crossref
Anamitra Ghosh, Michele M. ComerotaDebin WanFading ChenNicholas E. PropsonSung Hee Hwang, Bruce D. HammockHui Zheng. (2020) An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease. Science Translational Medicine 12:573.
Crossref
Crossref
A.V. Shchulkin, I.V. Chernykh, N.M. Popova, A.A. Slepnev & E.N. Yakusheva. (2020) Evaluation of female sex hormones influence on the protein-transporter p-glycoprotein functioning in vitro. Biomeditsinskaya Khimiya 66:6, pages 444-449.
Crossref
Crossref
Heba Elkateb, Lee M. Tatham, Helen Cauldbeck, Edyta Niezabitowska, Andrew Owen, Steve Rannard & Tom McDonald. (2020) Optimization of the synthetic parameters of lipid polymer hybrid nanoparticles dual loaded with darunavir and ritonavir for the treatment of HIV. International Journal of Pharmaceutics 588, pages 119794.
Crossref
Crossref
Pelageya D. Erokhina, Yulia V. Abalenikhina, Alexey V. Shchulkin, Ivan V. Chernykh, Natalia M. Popova, Alexandr A. Slepnev & Elena N. Yakusheva. (2020) A study of influence of progesterone on activity of Glycoprotein-P in vitro. I.P. Pavlov Russian Medical Biological Herald 28:2, pages 135-142.
Crossref
Crossref
Dawn Ernenwein, Sarah E. St. John, Alistair J. Stewart, Bruce H. Morimoto, Jean Chmielewski & Mark A. Lipton. (2020)
Structural studies and cyclization of the neuroprotective octapeptide
NAPVSIPQ
to improve cell permeability
. Peptide Science 112:4.
Crossref
Crossref
Kornphimol Kulthong, Loes Duivenvoorde, Huiyi Sun, Samuel Confederat, Jiaqing Wu, Bert Spenkelink, Laura de Haan, Victor Marin, Meike van der Zande & Hans Bouwmeester. (2020) Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models. Toxicology in Vitro 65, pages 104815.
Crossref
Crossref
Yu Fen Zheng, Soo Hyeon Bae, Zhouchi Huang, Soon Uk Chae, Seong Jun Jo, Hyung Joon Shim, Chae Bin Lee, Doyun Kim, Hunseung Yoo & Soo Kyung Bae. (2020) Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone. Pharmaceutics 12:4, pages 328.
Crossref
Crossref
I. V. Chernykh, A. V. Shchul’kin, E. E. Kirichenko, A. S. Esenina, M. M. Gradinar’, A. A. Slepnev & E. N. Yakusheva. (2020) Influence of Common Tansy (Tanacetum vulgare) Flower Polysaccharide Complex on P-Glycoprotein Transporter Activity in Vitro. Pharmaceutical Chemistry Journal 53:12, pages 1133-1136.
Crossref
Crossref
Hirokazu Wakuda, Takashi Okura, Kana Maruyama-Fumoto, Satomi Kagota, Yoshihiko Ito, Shino Miyauchi-Wakuda, Naoyuki Otani, Naoto Uemura, Shizuo Yamada & Kazumasa Shinozuka. (2019) Effects of Anticholinergic Drugs Used for the Therapy of Overactive Bladder on P-Glycoprotein Activity. Biological and Pharmaceutical Bulletin 42:12, pages 1996-2001.
Crossref
Crossref
Elena N. Yakusheva, Aleksey V. Shchulkin, Ivan V. Chernykh, Natalia M. Popova, Anna A. Kotlyarova & Alexandr A. Slepnev. (2019) Assessment of drugs belonging to inhibitors and inductors of p-glycoprotein in vitro. Reviews on Clinical Pharmacology and Drug Therapy 17:1, pages 71-78.
Crossref
Crossref
Alison C. Savage, Lee M. Tatham, Marco Siccardi, Trevor Scott, Manoli Vourvahis, Andrew Clark, Steve P. Rannard & Andrew Owen. (2019) Improving maraviroc oral bioavailability by formation of solid drug nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 138, pages 30-36.
Crossref
Crossref
Prachi Shekhawat, Milind Bagul, Diptee Edwankar & Varsha Pokharkar. (2019) Enhanced dissolution/caco-2 permeability, pharmacokinetic and pharmacodynamic performance of re-dispersible eprosartan mesylate nanopowder. European Journal of Pharmaceutical Sciences 132, pages 72-85.
Crossref
Crossref
Bahar Matin, Ahmad A Sherbini, Novera Alam, Jerold S Harmatz & David J Greenblatt. (2019)
Resveratrol glucuronidation
in vitro
: potential implications of inhibition by probenecid
. Journal of Pharmacy and Pharmacology 71:3, pages 371-378.
Crossref
Crossref
Dianlei Wang. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
203
240
.
Gabriel Kigen & Geoffrey Edwards. (2018) Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles. BMC Pharmacology and Toxicology 19:1.
Crossref
Crossref
Ashish Girdhar, Poonam Thakur, Sneha Sheokand & Arvind Bansal. (2018) Permeability Behavior of Nanocrystalline Solid Dispersion of Dipyridamole Generated Using NanoCrySP Technology. Pharmaceutics 10:3, pages 160.
Crossref
Crossref
Sophie Hodin, Thierry Basset, Elodie Jacqueroux, Olivier Delezay, Anthony Clotagatide, Nathalie Perek, Patrick Mismetti & Xavier Delavenne. (2017) In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition. European Journal of Drug Metabolism and Pharmacokinetics 43:2, pages 183-191.
Crossref
Crossref
Masayo Oishi, Yuma Takano, Yutaka Torita, Bimal Malhotra & Koji Chiba. (2018) Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole. Drug Metabolism and Pharmacokinetics 33:1, pages 90-95.
Crossref
Crossref
Burak Ozgür, Lasse Saaby, Kristine Langthaler & Birger Brodin. (2018) Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates. European Journal of Pharmaceutical Sciences 112, pages 112-121.
Crossref
Crossref
KP. Van Ness & EJ. Kelly. 2018. Comprehensive Toxicology. Comprehensive Toxicology
143
164
.
Lucia Disch, Kristina Forsch, Beate Siewert, Jürgen Drewe & Gert Fricker. (2017) In Vitro and In Situ Characterization of Triterpene Glycosides From Cimicifuga racemosa Extract. Journal of Pharmaceutical Sciences 106:12, pages 3642-3650.
Crossref
Crossref
Robert Elsby, Stephen Chidlaw, Samuel Outteridge, Sarah Pickering, Amy Radcliffe, Rebecca Sullivan, Hayley Jones & Philip Butler. (2017)
Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (
MATE
) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine
. Pharmacology Research & Perspectives 5:5.
Crossref
Crossref
Anton Ivanyuk, Françoise Livio, Jérôme Biollaz & Thierry Buclin. (2017) Renal Drug Transporters and Drug Interactions. Clinical Pharmacokinetics 56:8, pages 825-892.
Crossref
Crossref
Sue-Chih Lee, Vikram Arya, Xinning Yang, Donna A. Volpe & Lei Zhang. (2017) Evaluation of transporters in drug development: Current status and contemporary issues. Advanced Drug Delivery Reviews 116, pages 100-118.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
203
267
.
W. David HongPeter D. GibbonsSuet C. LeungRichard Amewu, Paul A. StocksAndrew StachulskiPedro Horta, Maria L. S. Cristiano, Alison E. ShoneDarren MossAlison ArdreyRaman SharmaAshley J. WarmanPaul T. P. BedingfieldNicholas E. FisherGhaith AljayyoussiSally MeadMaxine CawsNeil G. BerryStephen A. WardGiancarlo A. BiaginiPaul M. O’NeillGemma L. Nixon. (2017)
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of
Mycobacterium tuberculosis
. Journal of Medicinal Chemistry 60:9, pages 3703-3726.
Crossref
Crossref
Linda Fredlund, Susanne Winiwarter & Constanze Hilgendorf. (2017) In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development. Molecular Pharmaceutics 14:5, pages 1601-1609.
Crossref
Crossref
Hattan A. Alharbi, Jane Alcorn, Ahmed Al‐Mousa, John P. Giesy & Steve B. Wiseman. (2016) Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process‐affected water: evidence for inhibition of P‐glycoprotein. Journal of Applied Toxicology 37:5, pages 591-601.
Crossref
Crossref
Kaitlyn V. Ledwitch & Arthur G. Roberts. (2016) Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein. The AAPS Journal 19:2, pages 409-420.
Crossref
Crossref
Thérèse Sergent, Karine Croizet & Yves‐Jacques Schneider. (2016) In vitro investigation of intestinal transport mechanism of silicon, supplied as orthosilicic acid‐vanillin complex. Molecular Nutrition & Food Research 61:2.
Crossref
Crossref
Steingrimur Stefansson, Seunghyun Han, Ye In Jeon, David S. Chung, Peter Hwang, Huyen Le, John L. Warden & David Ho. (2017) Transporting Mammalian Cells at Ambient Temperature: A Viable Alternative to Dry Ice. Advances in Bioscience and Biotechnology 08:04, pages 127-133.
Crossref
Crossref
Bodil B. Carstens, Joakim Swedberg, Géza Berecki, David J. Adams, David J. Craik & Richard J. Clark. (2016) Effects of linker sequence modifications on the structure, stability, and biological activity of a cyclic α‐conotoxin. Peptide Science 106:6, pages 864-875.
Crossref
Crossref
Kaitlyn V. Ledwitch, Morgan E. Gibbs, Robert W. Barnes & Arthur G. Roberts. (2016) Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein. Biochemical Pharmacology 118, pages 96-108.
Crossref
Crossref
Annelaure Damont, Sébastien Goutal, Sylvain Auvity, Héric Valette, Bertrand Kuhnast, Wadad Saba & Nicolas Tournier. (2016) Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates. European Journal of Pharmaceutical Sciences 91, pages 98-104.
Crossref
Crossref
R. Elsby, P. Martin, D. Surry, P. Sharma & K. Fenner. (2015) Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure. Drug Metabolism and Disposition 44:3, pages 398-408.
Crossref
Crossref
Taylor A. Choi, Anna M. Furimsky, Robert Swezey, Deborah I. Bunin, Patricia Byrge, Lalitha V. Iyer, Polly Y. Chang & Rebecca J. Abergel. (2015) In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO). Journal of Pharmaceutical Sciences 104:5, pages 1832-1838.
Crossref
Crossref
Markus R. Meyer, Lea Wagmann, Nicole Schneider-Daum, Brigitta Loretz, Cristiane de Souza Carvalho, Claus-Michael Lehr & Hans H. Maurer. (2015) P-glycoprotein interactions of novel psychoactive substances – Stimulation of ATP consumption and transport across Caco-2 monolayers. Biochemical Pharmacology 94:3, pages 220-226.
Crossref
Crossref
Kathleen E. Sampson, Amanda Brinker, Jennifer Pratt, Neetu Venkatraman, Yongling Xiao, Jim Blasberg, Toni Steiner, Maureen Bourner & David C. Thompson. (2015) Zinc Finger Nuclease–Mediated Gene Knockout Results in Loss of Transport Activity for P-Glycoprotein, BCRP, and MRP2 in Caco-2 Cells. Drug Metabolism and Disposition 43:2, pages 199-207.
Crossref
Crossref
Fiona L. HattonFiona L. Hatton. 2015. Hyperbranched Polydendrons. Hyperbranched Polydendrons
117
170
.
Fiona L. HattonFiona L. Hatton. 2015. Hyperbranched Polydendrons. Hyperbranched Polydendrons
79
116
.
Bradley Croy Doak, Bjӧrn Over, Fabrizio Giordanetto & Jan Kihlberg. (2014) Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology 21:9, pages 1115-1142.
Crossref
Crossref
Márton Jani & Péter Krajcsi. (2014) In vitro methods in drug transporter interaction assessment. Drug Discovery Today: Technologies 12, pages e105-e112.
Crossref
Crossref
Edmund Hoppe, Nicola J. Hewitt, Hans-Peter Buchstaller, Hans-Michael Eggenweiler, Christian Sirrenberg, Astrid Zimmermann, Joachim März, Harry Schwartz, Christoph Saal, Michael Meyring & Stefan Hecht. (2014) A Novel Strategy for ADME Screening of Prodrugs: Combined Use of Serum and Hepatocytes to Integrate Bioactivation and Clearance, and Predict Exposure to Both Active and Prodrug to the Systemic Circulation. Journal of Pharmaceutical Sciences 103:5, pages 1504-1514.
Crossref
Crossref
Donna A. Volpe, Hong Shen & Praveen V. Balimane. 2014. Predictive ADMET. Predictive ADMET
263
290
.
Donna A. Volpe, Salaheldin S. Hamed & Lei K. Zhang. (2013) Use of Different Parameters and Equations for Calculation of IC50 Values in Efflux Assays: Potential Sources of Variability in IC50 Determination. The AAPS Journal 16:1, pages 172-180.
Crossref
Crossref
Yanyan Zhang, Yahui Hu, Yidong Feng, Nandani Darshika Kodithuwakku, Weirong Fang, Yunman Li & Wenlong Huang. (2014) The inhibitory and combinative mechanism of HZ08 with P-glycoprotein expressed on the membrane of Caco-2 cell line. Toxicology and Applied Pharmacology 274:2, pages 232-239.
Crossref
Crossref
Sid Bhoopathy, Chris Bode, Vatsala Naageshwaran, Erica A. Weiskircher-Hildebrandt & Ismael J. Hidalgo. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
229
252
.
Darren M. Moss, Neill J. Liptrott, Paul Curley, Marco Siccardi, David J. Back & Andrew Owen. (2013)
Rilpivirine Inhibits Drug Transporters ABCB1, SLC22A1, and SLC22A2
In Vitro
. Antimicrobial Agents and Chemotherapy 57:11, pages 5612-5618.
Crossref
Crossref
Lushan Yu, Qi Shen, Quan Zhou, Huidi Jiang, Huichang Bi, Min Huang, Hui Zhou & Su Zeng. (2013) In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs. Journal of Ethnopharmacology 150:2, pages 485-491.
Crossref
Crossref
Sibylle Neuhoff, Karen Rowland Yeo, Zoe Barter, Masoud Jamei, David B. Turner & Amin Rostami‐Hodjegan. (2013) Application of permeability‐limited physiologically-based pharmacokinetic models: Part II-prediction of p‐glycoprotein mediated drug–drug interactions with digoxin. Journal of Pharmaceutical Sciences 102:9, pages 3161-3173.
Crossref
Crossref
Hai Pham-The, Teresa Garrigues, Marival Bermejo, Isabel González-Álvarez, Maikel Cruz Monteagudo & Miguel Ángel Cabrera-Pérez. (2013)
Provisional Classification and
in Silico
Study of Biopharmaceutical System Based on Caco-2 Cell Permeability and Dose Number
. Molecular Pharmaceutics 10:6, pages 2445-2461.
Crossref
Crossref
David Dickens, Andrew Owen, Ana Alfirevic & Munir Pirmohamed. (2013) ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein. Pharmacogenetics and Genomics 23:6, pages 314-323.
Crossref
Crossref
Donglu Zhang, Kan He, John J. Herbst, Janet Kolb, Wilson Shou, Lifei Wang, Praveen V. Balimane, Yong-Hae Han, Jinping Gan, Charles E. Frost & W. Griffith Humphreys. (2013) Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban. Drug Metabolism and Disposition 41:4, pages 827-835.
Crossref
Crossref
Nobuhiko Fushimi, Hirotaka Teranishi, Kazuo Shimizu, Shigeru Yonekubo, Kohsuke Ohno, Takashi Miyagi, Fumiaki Itoh, Toshihide Shibazaki, Masaki Tomae, Yukiko Ishikawa-Takemura, Takeshi Nakabayashi, Noboru Kamada, Yuji Yamauchi, Susumu Kobayashi & Masayuki Isaji. (2013) Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1). Bioorganic & Medicinal Chemistry 21:3, pages 748-765.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
147
259
.
Michael Schmohl, Nicole Schneiderhan-Marra, Nadja Baur, Kathrin Hefner, Michael Blum, Gerburg M. Stein, Thomas O. Joos & Manfred Schmolz. (2012) Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood. International Immunopharmacology 14:4, pages 722-728.
Crossref
Crossref
Jibin Li, Ying Wang, Wei Zhang, Yuehua Huang, Kristin Hein & Ismael J. Hidalgo. (2012) The Role of a Basolateral Transporter in Rosuvastatin Transport and Its Interplay with Apical Breast Cancer Resistance Protein in Polarized Cell Monolayer Systems. Drug Metabolism and Disposition 40:11, pages 2102-2108.
Crossref
Crossref
Darren M. Moss, Marco Siccardi, Matthew Murphy, Michael M. Piperakis, Saye H. Khoo, David J. Back & Andrew Owen. (2012)
Divalent Metals and pH Alter Raltegravir Disposition
In Vitro
. Antimicrobial Agents and Chemotherapy 56:6, pages 3020-3026.
Crossref
Crossref
Kirsten Mease, Rucha Sane, Lalitha Podila & Mitchell E. Taub. (2012) Differential Selectivity of Efflux Transporter Inhibitors in Caco-2 and MDCK–MDR1 Monolayers: A Strategy to Assess the Interaction of a New Chemical Entity with P-gp, BCRP, and MRP2. Journal of Pharmaceutical Sciences 101:5, pages 1888-1897.
Crossref
Crossref
Alexander V. LyubimovWalter A. Korfmacher. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
18
.
Fabio Broccatelli, Caroline A. Larregieu, Gabriele Cruciani, Tudor I. Oprea & Leslie Z. Benet. (2012) Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Advanced Drug Delivery Reviews 64:1, pages 95-109.
Crossref
Crossref
Amit S. Kalgutkar, Meera Tugnait, Tong Zhu, Emi Kimoto, Zhuang Miao, Vincent Mascitti, Xin Yang, Beijing Tan, Robert L. Walsky, Jonathan Chupka, Bo Feng & Ralph P. Robinson. (2011) Preclinical Species and Human Disposition of PF-04971729, a Selective Inhibitor of the Sodium-Dependent Glucose Cotransporter 2 and Clinical Candidate for the Treatment of Type 2 Diabetes Mellitus. Drug Metabolism and Disposition 39:9, pages 1609-1619.
Crossref
Crossref
Jibin Li, Donna A. Volpe, Ying Wang, Wei Zhang, Chris Bode, Albert Owen & Ismael J. Hidalgo. (2011) Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs. Drug Metabolism and Disposition 39:7, pages 1196-1202.
Crossref
Crossref
J.M. Kratz, M.R. Teixeira, L.S. Koester & C.M.O. Simões. (2011) An HPLC-UV method for the measurement of permeability of marker drugs in the Caco-2 cell assay. Brazilian Journal of Medical and Biological Research 44:6, pages 531-537.
Crossref
Crossref
K. Schroeder, K.D. Bremm, N. Alépée, J.G.M. Bessems, B. Blaauboer, S.N. Boehn, C. Burek, S. Coecke, L. Gombau, N.J. Hewitt, J. Heylings, J. Huwyler, M. Jaeger, M. Jagelavicius, N. Jarrett, H. Ketelslegers, I. Kocina, J. Koester, J. Kreysa, R. Note, A. Poth, M. Radtke, V. Rogiers, J. Scheel, T. Schulz, H. Steinkellner, M. Toeroek, M. Whelan, P. Winkler & W. Diembeck. (2011) Report from the EPAA workshop: In vitro ADME in safety testing used by EPAA industry sectors. Toxicology in Vitro 25:3, pages 589-604.
Crossref
Crossref
Darren M. Moss, Wai San Kwan, Neill J. Liptrott, Darren L. Smith, Marco Siccardi, Saye H. Khoo, David J. Back & Andrew Owen. (2011) Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir. Antimicrobial Agents and Chemotherapy 55:2, pages 879-887.
Crossref
Crossref
Robert Elsby, Michael Gillen, Caroline Butters, Gemma Imisson, Pradeep Sharma, Veronica Smith & Dominic D. Surry. (2011) The Utility of In Vitro Data in Making Accurate Predictions of Human P-Glycoprotein-Mediated Drug-Drug Interactions: A Case Study for AZD5672. Drug Metabolism and Disposition 39:2, pages 275-282.
Crossref
Crossref
Mia Birkhøj Kjærstad, Flemming Nielsen, Lene Nøhr-Jensen, Stine Zwisler, Kim Brøsen & Helle Raun Andersen. (2010) Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women. European Journal of Clinical Pharmacology 66:12, pages 1189-1197.
Crossref
Crossref
Mohammad M. Al‐Bataineh, Deon van der Merwe, Bruce D. Schultz & Ronette Gehring. (2010)
Tumor necrosis factor alpha increases P‐glycoprotein expression in a BME‐UV
in vitro
model of mammary epithelial cells
. Biopharmaceutics & Drug Disposition 31:8-9, pages 506-515.
Crossref
Crossref
Anand G. Patil, Dilip Reddy, Russell D'Souza & Anagha Damre. (2009) Development and validation of RP‐HPLC‐fluorescence method for quantitative determination of quinidine, a probe substrate for P‐glycoprotein inhibition assay using Caco‐2 cell monolayer. Biomedical Chromatography 24:6, pages 620-625.
Crossref
Crossref
April C. Braddy & Andre J. Jackson. (2010) Role of metabolites for drugs that undergo nonlinear first-pass effect: Impact on bioequivalency assessment using single-dose simulations. Journal of Pharmaceutical Sciences 99:1, pages 515-523.
Crossref
Crossref
Nuggehally R. Srinivas. (2009) Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection. Drug Metabolism and Pharmacokinetics 24:2, pages 194-196.
Crossref
Crossref